MedTrace Logo

Tailored Communication to Reduce Cardiovascular Risk

NCT01286311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 464

Last updated 2015-02-09

Study results available
· View outcomes & findings →

Summary

The primary goal of the trial is to test the feasibility and efficacy of a cardiovascular disease quality improvement system that couples EMR-based patient identification with individually tailored patient messages. The study will test the hypothesis that that a tailored patient-directed approach to cardiovascular risk reduction integrated into patients' primary care delivery site will improve control of elevated low-density lipoprotein cholesterol and other card iac risk factors more than routine care alone for patients at intermediate or high risk for cardiovascular disease.

Conditions

Interventions

BEHAVIORAL

Direct-to-patient tailored cardiovascular risk message system

Patient informational mailings

Sponsors & Collaborators

Principal Investigators

  • Stephen Persell, MD, MPH · Northwestern University Division of General Internal Medicine, Feinberg School of Medicine and Institute for Healthcare Studies

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01286311 on ClinicalTrials.gov